Growth Metrics

Pulmonx (LUNG) Return on Capital Employed (2020 - 2025)

Historic Return on Capital Employed for Pulmonx (LUNG) over the last 6 years, with Q3 2025 value amounting to 0.48%.

  • Pulmonx's Return on Capital Employed fell 900.0% to 0.48% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.48%, marking a year-over-year decrease of 900.0%. This contributed to the annual value of 0.4% for FY2024, which is 100.0% down from last year.
  • As of Q3 2025, Pulmonx's Return on Capital Employed stood at 0.48%, which was down 900.0% from 0.45% recorded in Q2 2025.
  • Pulmonx's 5-year Return on Capital Employed high stood at 0.16% for Q1 2021, and its period low was 0.48% during Q3 2025.
  • In the last 5 years, Pulmonx's Return on Capital Employed had a median value of 0.35% in 2023 and averaged 0.33%.
  • Its Return on Capital Employed has fluctuated over the past 5 years, first changed by 0bps in 2021, then crashed by -1200bps in 2022.
  • Over the past 5 years, Pulmonx's Return on Capital Employed (Quarter) stood at 0.21% in 2021, then plummeted by -54bps to 0.33% in 2022, then decreased by -20bps to 0.39% in 2023, then fell by -5bps to 0.41% in 2024, then fell by -16bps to 0.48% in 2025.
  • Its Return on Capital Employed was 0.48% in Q3 2025, compared to 0.45% in Q2 2025 and 0.44% in Q1 2025.